Vir Biotechnology
Latest round
- Seed
Last raised
- Jan 2017
Total raised
- Undisclosed
Investors
- 4
About Vir Biotechnology
Based in the US, Vir Biotechnology, Inc.Vir Biotechnology, Inc. was founded in 2016 and operates out of San Francisco, US. The company specializes in the development of therapies targeting infectious diseases and cancer using its own proprietary technologies. The founder, Robert Nelsen, has a background in biotechnology and has previously been involved in founding other companies. In October 2023, Vir Biotechnology, Inc.Vir Biotechnology is dedicated to creating advanced therapies utilizing its next-generation antibody platform and the proprietary PRO-XTEN™ protease-releasable masking technology. The company’s initiatives focus on chronic hepatitis delta, COVID-19, and Ebola, with products designed to enhance immune responses.Vir Biotechnology plans to launch upcoming products developed from its advanced antibody platform and PRO-XTEN™ technology, although specific release dates have not been disclosed. The company is also targeting expansion into new international markets, with strategic efforts focused on Europe and Asia.
Who invested in Vir Biotechnology
4 investors across 1 round
See all investors in Vir Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Jan 6, 2017
Amount
Undisclosed
Investors
Questions about Vir Biotechnology
Who invested in Vir Biotechnology?
Vir Biotechnology has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vir Biotechnology raised?
Vir Biotechnology has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Vir Biotechnology last raise money?
Vir Biotechnology's most recent round on record is a Seed, in Jan 2017.
What does Vir Biotechnology do?
Based in the US, Vir Biotechnology, Inc.
Where is Vir Biotechnology headquartered?
Vir Biotechnology is headquartered in San Francisco, US.
Which VCs invest in companies like Vir Biotechnology?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vir Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Vir Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.